Relmada Therapeutics (RLMD) Receivables - Other (2016 - 2022)
Relmada Therapeutics (RLMD) reported Receivables - Other of $512432.0 for Q4 2022, down 85.8% on a QoQ basis from $3.6 million in Q1 2022.
Relmada Therapeutics (RLMD) has 7 years of Receivables - Other data on file, last reported at $512432.0 in Q4 2022.
- Quarterly Receivables - Other changed N/A year-over-year to $512432.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $512432.0 (changed N/A YoY) and the FY2022 annual result came in at $512432.0, changed N/A from the prior year.
- Receivables - Other fell to $512432.0 in Q4 2022 per RLMD's latest filing, from $3.6 million in the prior quarter.
- Across five years, Receivables - Other topped out at $3.6 million in Q1 2022 and bottomed at $7529.0 in Q1 2020.
- The 5-year median for Receivables - Other is $74649.5 (2019), against an average of $418992.1.
- The widest annual swing landed in 2020, when Receivables - Other sank 89.03%; it then jumped 4348.55% in 2022.
- Tracing RLMD's Receivables - Other over 5 years: stood at $67235.0 in 2018, then gained by 8.71% to $73091.0 in 2019, then grew by 8.71% to $79457.0 in 2020, then soared by 1925.01% to $1.6 million in 2021, then slumped by 68.15% to $512432.0 in 2022.
- Per Business Quant, the three latest RLMD Receivables - Other figures stand at $512432.0 (Q4 2022), $3.6 million (Q1 2022), and $1.6 million (Q3 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Relmada Therapeutics | 595.35 Mn | 595.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 512,432.00 |
| Dec 31, 2022 | 512,432.00 |
| Mar 31, 2022 | 3.61 Mn |
| Mar 31, 2022 | 3.61 Mn |
| Sep 30, 2021 | 1.61 Mn |
| Sep 30, 2021 | 1.61 Mn |
| Mar 31, 2021 | 81,133.00 |
| Mar 31, 2021 | 81,133.00 |
| Dec 31, 2020 | 79,457.00 |
| Dec 31, 2020 | 79,457.00 |
| Sep 30, 2020 | 77,815.00 |
| Sep 30, 2020 | 77,815.00 |
| Jun 30, 2020 | 76,208.00 |
| Jun 30, 2020 | 76,208.00 |
| Mar 31, 2020 | 7,529.00 |
| Mar 31, 2020 | 7,529.00 |
| Dec 31, 2019 | 73,091.00 |
| Dec 31, 2019 | 73,091.00 |
| Sep 30, 2019 | 71,581.00 |
| Sep 30, 2019 | 71,581.00 |
| Jun 30, 2019 | 177,000.00 |
| Jun 30, 2019 | 177,000.00 |
| Mar 31, 2019 | 68,654.00 |
| Mar 31, 2019 | 68,654.00 |
| Dec 31, 2018 | 67,235.00 |
| Dec 31, 2018 | 67,235.00 |
| Sep 30, 2018 | 65,846.00 |
| Sep 30, 2018 | 65,846.00 |
| Jun 30, 2018 | 64,486.00 |
| Jun 30, 2018 | 64,486.00 |
| Mar 31, 2018 | 63,153.00 |
| Mar 31, 2018 | 63,153.00 |
| Dec 31, 2017 | 61,849.00 |
| Dec 31, 2017 | 61,849.00 |
| Sep 30, 2017 | 150,617.00 |
| Sep 30, 2017 | 150,617.00 |
| Jun 30, 2017 | 232,597.00 |
| Jun 30, 2017 | 232,597.00 |
| Dec 31, 2016 | 2,350.00 |
| Dec 31, 2016 | 2,350.00 |
| Sep 30, 2016 | 2,350.00 |
| Sep 30, 2016 | 2,350.00 |
| Jun 30, 2016 | 231,942.00 |
| Jun 30, 2016 | 231,942.00 |